Table 1.
Characteristics of studies on the management and outcome of intracranial fungal infections in Africa
| Characteristic | Frequency (percentage) |
|---|---|
| Study setting (n=132 as one study was conducted in two countries) | |
| South Africa | 29 (22.0) |
| Uganda | 20 (15.1) |
| Zimbabwe | 10 (7.6) |
| Nigeria | 9 (6.8) |
| Malawi | 8 (6.1) |
| Morocco | 8 (6.1) |
| Tunisia | 6 (4.5) |
| Ivory coast | 5 (3.8) |
| Egypt | 5 (3.8) |
| Kenya | 4 (3.0) |
| Senegal | 3 (2.3) |
| Ethiopia | 3 (2.3) |
| Botswana | 3 (2.3) |
| Tanzania | 3 (2.3) |
| Central African Republic | 2 (1.5) |
| Gabon | 2 (1.5) |
| Rwanda | 2 (1.5) |
| Algeria | 1 (0.7) |
| Burkina Faso | 1 (0.7) |
| Equatorial Guinea | 1 (0.7) |
| Guinea-Bissau | 1 (0.7) |
| Lesotho | 1 (0.7) |
| Libya | 1 (0.7) |
| Madagascar | 1 (0.7) |
| Mali | 1 (0.7) |
| Mozambique | 1 (0.7) |
| Republic of Congo | 1 (0.7) |
| Year of publication | |
| 1970-1979 | 2 (1.5) |
| 1980-1989 | 4 (3.0) |
| 1990-1999 | 12 (9.2) |
| 2000-2009 | 28 (21.4) |
| 2010-2019 | 72 (55.0) |
| 2020-2021 | 13 (9.9) |
| Study design | |
| Case report | 50 (38.2) |
| Prospective cohort study | 27 (20.6) |
| Retrospective cohort study | 21 (16.0) |
| Case series | 13 (10.0) |
| Randomised controlled trials | 10 (7.6) |
| Cross-sectional study | 5 (3.8) |
| Cohort study | 3 (2.3) |
| Nested study | 1 (0.8) |
| Audit | 1 (0.8) |